Efficacy and safety of artemisinin-based combination therapy, and molecular markers for artemisinin and piperaquine resistance in Mainland Tanzania

Efficacy and safety of artemisinin-based combination therapy, and molecular markers for artemisinin and piperaquine resistance in Mainland Tanzania

Abstract Background Artemisinin-based combination therapy (ACT) is the first-line anti-malarial treatment of uncomplicated malaria in most malaria endemic countries, including Tanzania. Unfortunately, there have been reports of artemisinin resistance and ACT failure from South East Asia highlighting...

Full description

Bibliographic Details
Main Authors: Mwaka A. Kakolwa, Muhidin K. Mahende, Deus S. Ishengoma, Celine I. Mandara, Billy Ngasala, Erasmus Kamugisha, Johannes B. Kataraihya, Renata Mandike, Sigsbert Mkude, Frank Chacky, Ritha Njau, Zul Premji, Martha M. Lemnge, Marian Warsame, Didier Menard, Abdunoor M. Kabanywanyi
Format: Article
Language:English
Published: BMC 2018-10-01
Series:Malaria Journal
Subjects:
Artemisinin-based combination therapy
Efficacy
Safety
Malaria
Molecular markers
Artemisinin
Online Access:http://link.springer.com/article/10.1186/s12936-018-2524-x

Internet

http://link.springer.com/article/10.1186/s12936-018-2524-x

Similar Items